What Not to Take with Cross-Sex Hormones? Essential Safety Information Before You Start
What Not to Take with Cross-Sex Hormones? Essential Safety Information Before You Start — Thai Sisterhood

The use of cross-sex hormones (also called gender-affirming hormones) is a major step for transgender individuals who wish to align their physical appearance with their gender identity. These hormones, including estrogen for male-to-female (MTF) transition and testosterone for female-to-male (FTM) transition, play an important role in body transformation, mental well-being, and overall quality of life.

However, many overlook one critical aspect: drug interactions. Cross-sex hormones can interact with certain medications, supplements, and even lifestyle habits. These interactions may reduce the effectiveness of hormone therapy or cause serious health complications.

This article explores in depth the crucial question: “What should not be taken with cross-sex hormones?”

What Are Cross-Sex Hormones and How Do They Work?

Cross-sex hormones are not just “transition medications.” They regulate a wide range of body functions, affecting cardiovascular, hepatic (liver), endocrine, and reproductive systems.

  • Estrogen (for MTF): Stimulates breast development, redistributes body fat, reduces body hair, but also increases blood clot risks.
  • Progesterone (sometimes added in MTF regimens): May enhance breast development but raises clotting risks.
  • Testosterone (for FTM): Deepens voice, increases muscle mass, promotes hair growth, strengthens bones, but can affect liver and heart health.

Hormone levels are carefully adjusted to match the target gender range. This requires close monitoring, as underlying health conditions such as diabetes, liver disease, or hypertension increase the risk of complications.

Anticoagulants and Blood-Thinning Medications

Estrogen is well-known to increase the risk of blood clots (thrombosis), such as deep vein thrombosis (DVT) or pulmonary embolism. When combined with anticoagulants, the risks multiply.

  • Warfarin
  • Heparin
  • Aspirin, Clopidogrel

These drugs can destabilize clotting balance, making patients vulnerable to both excessive bleeding and clotting complications if not managed properly.

Case Study: Patients on estrogen and Warfarin have shown unstable INR levels, resulting in an increased risk of brain hemorrhage.

Antiretroviral Therapy (ART) for HIV

Many transgender individuals are also on antiretroviral therapy (ARVs) for HIV. Unfortunately, several ARVs interact directly with hormones.

  • Protease Inhibitors (Ritonavir, Lopinavir): Inhibit hormone metabolism → risk of dangerously high hormone levels → liver inflammation.
  • NNRTIs (Efavirenz): Accelerate hormone metabolism → lower hormone levels → poor feminization/masculinization outcomes.
  • WPATH (World Professional Association for Transgender Health) recommends regular hormone level and viral load monitoring for transgender patients on ART to ensure safe and effective outcomes.

Antibiotics That Accelerate Hormone Breakdown

Certain antibiotics, especially Rifampicin and Rifabutin (commonly used for tuberculosis treatment), strongly activate liver enzymes (CYP450). This causes hormones like estrogen or testosterone to break down too quickly, resulting in ineffective hormone therapy.

Patients on these antibiotics often require dose adjustments under close medical supervision.

Antidepressants and Psychiatric Medications

Some psychiatric medications can alter hormone metabolism or increase side effects:

  • SSRIs (Fluoxetine, Sertraline): Can affect hormone processing.
  • Mood stabilizers (Lithium, Valproate): Increase risks of hormone imbalance, mood instability, or sleep disturbances.

Because gender dysphoria often coexists with depression, careful psychiatric-hormonal coordination is essential.

Chemotherapy and Patients with Cancer History

For individuals with a history of hormone-sensitive cancers — such as breast cancer, ovarian cancer, or prostate cancer — the use of cross-sex hormones is a major caution point.

Estrogen or testosterone may stimulate cancer growth. Physicians typically conduct cancer screenings before approving hormone therapy, and may withhold treatment depending on the risks.

Herbal Supplements and Over-the-Counter Products

Many consider herbal products “safe,” but some directly interfere with hormone therapy:

Supplement/HerbEffect on Hormones
St. John’s WortRapidly lowers hormone blood levels
GinsengMay raise blood pressure
Ginkgo BilobaIncreases risk of abnormal bleeding
Phytoestrogens (Soy extracts, plant estrogens)Disrupt estrogen therapy effects

This highlights the importance of disclosing all supplements to healthcare providers before starting hormones.

Alcohol and Smoking: Silent Enemies of Hormone Users

Both alcohol and cigarette smoking significantly worsen hormone-related risks.

  • Smoking + Estrogen: Increases stroke and heart disease risk by 3–6 times.
  • Alcohol + Hormones: Overloads the liver, increasing risks of hepatitis and liver failure.

This is why many physicians strongly advise quitting smoking and minimizing alcohol before initiating hormone therapy.

Lifestyle Factors to Avoid During Hormone Use

Beyond prescription drugs, other lifestyle choices can endanger hormone users:

  • Recreational drug use (Meth, Cocaine, Ketamine): Severe risks for liver, cardiovascular, and neurological systems.
  • Anabolic steroids: Intensify liver stress, worsen hormone imbalance.
  • Unsafe diet pills: Disrupt hormone metabolism and elevate heart risks.

Why Regular Health Monitoring Is Crucial

According to WHO and WPATH guidelines, transgender patients on hormone therapy should undergo:

  • Blood tests every 3–6 months (hormone levels, liver/kidney function, cholesterol).
  • Blood pressure and cardiac health assessments.
  • Cancer screening based on birth anatomy (breast cancer, cervical cancer, prostate cancer).

These checks ensure hormone therapy is both effective and safe.

Cross-sex hormones are powerful and life-changing, but not all substances mix well with them. Certain medications, herbal supplements, and lifestyle habits can compromise safety or effectiveness. Risks range from liver inflammation and blood clots to cardiovascular disease and cancer recurrence.

The safest path is medical supervision. Regular monitoring, open communication with healthcare providers, and awareness of dangerous drug interactions allow transgender individuals to continue their gender journey safely and confidently.

REFERENCES

Sources and further reading

Primary and authoritative sources used for context and fact-checking.

  1. Frequently asked questions on sexual and gender diversity, health and human rights World Health Organization (WHO)
  2. The Thai Handbook of Transgender Healthcare Services IHRI & Center of Excellence in Transgender Health, Chulalongkorn University
  3. Standards of Care for the Health of Transgender and Gender Diverse People, Version 8 World Professional Association for Transgender Health (WPATH)
  4. Consolidated guidelines on HIV, viral hepatitis and STI for key populations (2022) World Health Organization (WHO)
  5. STI Treatment Guidelines: Transgender and Gender Diverse Persons U.S. Centers for Disease Control and Prevention (CDC)
Links were selected from official organizations and trusted primary sources. External content may be updated by its publisher.